HAEMONETICS CORP - 8-K Filing
Haemonetics shareholders approved plan amendments authorizing additional shares for issuance through 2036 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 below, on July 24, 2026, the shareholders of the Company approved an amendment and restatement of the Haemonetics Corporation Amended and Res, 9.01 Financial Statements and Exhibits)
Tickers: $HAE